Clinical Trial

New Methods for Evaluating Preventive Migraine Treatment

Recruiting
View on ClinicalTrials.gov →
Summary
The study aims to test interactions between drug and placebo-responses in acute migraine treatment and to assess variation in adverse events according to treatment information provided. Using a clinical within-subjects, balanced placebo design, patients with chronic migraine will receive four treatment conditions in a randomized order.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-08; most recent amendment 2026-05-18.
Trial Details
NCT Number NCT07071506
Lead Sponsor University of Aarhus
Conditions Migraine, Migraine With or Without Aura, Headache Disorders, Chronic Migraine, Headache
Enrollment 60 participants
Start Date 2025-06-19
Primary Completion 2028-09 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2026-05-19